| Two phase 3 trials of dupilumab versus placebo in atopic dermatitis EL Simpson, T Bieber, E Guttman-Yassky, LA Beck, A Blauvelt, MJ Cork, ... New England Journal of Medicine 375 (24), 2335-2348, 2016 | 1748 | 2016 |
| Staging of classic Kaposi’s sarcoma: a useful tool for therapeutic choices L Brambilla, V Boneschi, M Taglioni, S Ferrucci European Journal of Dermatology 13 (1), 83-6, 2003 | 151 | 2003 |
| Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients AV Marzano, G Genovese, G Casazza, MT Fierro, P Dapavo, N Crimi, ... Journal of the European Academy of Dermatology and Venereology 33 (5), 918-924, 2019 | 116 | 2019 |
| D-dimer plasma levels parallel the clinical response to omalizumab in patients with severe chronic spontaneous urticaria R Asero, AV Marzano, S Ferrucci, M Cugno International Archives of Allergy and Immunology 172 (1), 40-44, 2017 | 89 | 2017 |
| HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma R Mancuso, R Biffi, M Valli, M Bellinvia, T Athanasia, S Ferrucci, ... Journal of medical virology 80 (12), 2153-2160, 2008 | 84 | 2008 |
| Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study C Patruno, M Napolitano, G Argenziano, K Peris, M Ortoncelli, ... Journal of the European Academy of Dermatology and Venereology 35 (4), 958-964, 2021 | 81 | 2021 |
| Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases L Brambilla, A Romanelli, M Bellinvia, S Ferrucci, M Vinci, V Boneschi, ... British Journal of Dermatology 158 (6), 1339-1344, 2008 | 79 | 2008 |
| Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis MC Fargnoli, M Esposito, S Ferrucci, G Girolomoni, A Offidani, A Patrizi, ... Journal of Dermatological Treatment 32 (5), 507-513, 2021 | 76 | 2021 |
| The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria E Kocatürk, A Salman, I Cherrez‐Ojeda, PR Criado, J Peter, ... Allergy, 2020 | 71 | 2020 |
| Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria R Asero, AV Marzano, S Ferrucci, M Lorini, V Carbonelli, M Cugno Clinical & Experimental Immunology 200 (3), 242-249, 2020 | 66 | 2020 |
| Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports S Ferrucci, M Romagnuolo, L Angileri, E Berti, S Tavecchio Journal of the European Academy of Dermatology and Venereology 34 (7), e303-e304, 2020 | 65 | 2020 |
| Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma S Della Bella, S Nicola, L Brambilla, A Riva, S Ferrucci, P Presicce, ... Clinical Immunology 119 (3), 317-329, 2006 | 64 | 2006 |
| Elevated IgE to tissue factor and thyroglobulin are abated by omalizumab in chronic spontaneous urticaria. M Cugno, R Asero, S Ferrucci, M Lorini, V Carbonelli, A Tedeschi, ... Allergy 73 (12), 2408-2411, 2018 | 61 | 2018 |
| Italian guidelines for therapy of atopic dermatitis—Adapted from consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) G Damiani, P Calzavara‐Pinton, L Stingeni, K Hansel, F Cusano, ... Dermatologic Therapy 32 (6), e13121, 2019 | 56 | 2019 |
| Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma L Brambilla, A Miedico, S Ferrucci, A Romanelli, M Brambati, M Vinci, ... Journal of the European Academy of Dermatology and Venereology 20 (9), 1090-1094, 2006 | 54 | 2006 |
| Use of dupilumab in 543 adult patients with moderate-to-severe atopic dermatitis: a multicenter, retrospective study MD Elisabetta Di Leo J. Investig. Allergol. Clin. Immunol 32, 124-132, 2022 | 53 | 2022 |
| Clinical response and quality of life in patients with severe atopic dermatitis treated with dupilumab: a single-center real-life experience S Ferrucci, G Casazza, L Angileri, S Tavecchio, F Germiniasi, E Berti, ... Journal of Clinical Medicine 9 (3), 791, 2020 | 50 | 2020 |
| Efficacy and safety of lebrikizumab in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis: a randomized clinical trial … EL Simpson, M Gooderham, A Wollenberg, S Weidinger, A Armstrong, ... JAMA dermatology 159 (2), 182-191, 2023 | 44 | 2023 |
| A multicenter study on the prevalence of clinical patterns and clinical phenotypes in adult atopic dermatitis E Nettis, M Ortoncelli, G Pellacani, C Foti, E Di Leo, C Patruno, ... J. Investig. Allergol. Clin. Immunol, 448-450, 2020 | 44 | 2020 |
| Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis: our experience of efficacy S Ferrucci, S Tavecchio, E Berti, L Angileri Journal of Dermatological Treatment 32 (4), 453-454, 2021 | 41 | 2021 |
